arrow
N

Neil French

University of Liverpool
H指数:57
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evidence needs and community involvement in policy decisions for vaccine-preventable diarrhoeal infections among children under the age of five years: Stakeholder engagement in Ethiopia, Kenya, and Malawi

证据需求及社区参与在五岁以下儿童可接种疫苗预防性腹泻感染的政策决策中的作用:埃塞俄比亚、肯尼亚和马拉维的利益相关者参与情况

2025-12-010
PRE
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi

RTS,S/AS01E疟疾疫苗在真实世界环境下的有效性:在三剂基础免疫程序后1年的随访期内的中期分析——一项在加纳、肯尼亚和马拉维开展的4期研究

2025-11-060
OAAI
Relationship Between Group 3 Innate Lymphoid Cells and Th17 in Human Nasopharynx-Associated Lymphoid Tissue and the Association With Pneumococcal Carriage

人类鼻咽相关淋巴组织中第三组先天淋巴细胞与Th17的关系及其与肺炎球菌携带状态的关联

2025-10-010
PRE
High Propensity for Multidrug-Resistant Pneumococcal Shedding Among Adults Living With HIV on Stable Antiretroviral Therapy in Malawi

马拉维接受稳定抗逆转录病毒治疗的HIV感染者中,肺炎链球菌多药耐药分离株高易感性。

2025-08-011
OA
Safety of RTS,S/AS01E malaria vaccine up to 1 year after the third dose in Ghana, Kenya, and Malawi (EPI-MAL-003): a phase 4 cohort event monitoring study

RTS,S/AS01E疟疾疫苗在第三剂接种后1年内的安全性(Ghana、Kenya和Malawi)(EPI-MAL-003):一项4期队列事件监测研究

2025-04-240
OAAI
Diversity in Naturally Acquired Immunity to Group B Streptococcus: A Comparative Study of Women From Bangladesh, Malawi, and the United Kingdom

对B组链球菌的自然获得性免疫的多样性: 来自孟加拉国,马拉维和英国的妇女的比较研究

2024-12-180
PRE
Genomic insights into the 2022-2023Vibrio cholerae outbreak in Malawi
2024-07-260
OAAI
The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi

在马拉维城市引入PCV13后,肺炎链球菌的代谢,毒力和抗菌素耐药性转移

2023-11-174
OAAI
Optimal age targeting for pneumococcal vaccination in older adults; a modelling study

老年人肺炎球菌疫苗接种的最佳年龄目标; 建模研究

2023-02-162
OAAI
Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3+0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population- level, serosurveillance study

马拉维布兰太尔5岁以下儿童在生命的第一年内使用3 0时间表,由13价肺炎球菌结合疫苗诱导的抗体水平下降: 一项观察性,人群水平,血清监测研究

2022-12-0126
OAAI